In an industrial collaboration project, TU Wien has developed a medication that can alleviate or even completely eliminate the symptoms of celiac disease. It should be available as early as 2021.
Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.
Although efforts are already being made to treat celiac disease, the proposed drugs have an effect on the immune system. Possible side effects must therefore be examined very carefully. Although initial clinical studies are underway, they will not lead to a marketable product in the next few years.
For this reason, an entirely different approach has been pursued at TU Wien in collaboration with the industrial partner Sciotech Diagnostic Technologies GmbH. Instead of developing a drug that interferes with the immune system, TU Wien has created a simple medical product that directly attacks the gluten molecules to render them harmless. This makes the approval process much simpler, meaning that the product should be available in ordinary pharmacies as early as 2021.
Molecules like keys and locks
“Our bodies produce antibodies that fit intruding antigens precisely, like a key to a lock. This immune response makes these antigens harmless,” explains Professor Oliver Spadiut, head of the Integrated Bioprocess Development Research Group at TU Wien. “If a new antibody fragment is found and produced that docks to and blocks the invading gluten molecule without triggering the immune system, the symptoms of celiac disease can be suppressed.”
The aim of the research project was therefore to produce a complex of two such antibody fragments that envelop the gluten molecule at a molecular level, so that it can no longer have any further effects in the intestines.
To do this, certain bacteria have to be reprogrammed so that they produce exactly the desired antibody fragment. “The formation of such proteins in a bacterium is a highly complicated process,” explains Oliver Spadiut. “It can easily happen that the proteins are not folded exactly as we want.” Instead of the desired antibody fragments, so-called “inclusion bodies” are formed – small particles consisting of incorrectly folded proteins. A process therefore had to be developed to refold these inclusion bodies and to obtain the desired proteins from them.
Such processes, in which the folding of proteins is specifically altered, have not yet been studied in great detail and so they are not very efficient. “You have to precisely understand the chemical processes involved and intervene in a complicated way,” says Oliver Spadiut. “It has therefore taken a while, but we have now developed a process that can be easily reproduced, can be scaled up to industrial application and delivers a very good yield of the desired product”
In pharmacies soon
The project was supported by the industrial partner SCIOTEC Diagnostic Technologies GmbH, who will now bring the new medical product to the market. “It will be a preparation that celiac patients can take together with gluten-containing foods to alleviate coeliac symptoms,” explains Oliver Spadiut. “It remains to be seen whether the symptoms will disappear completely or will only be alleviated. The precise effects will probably vary from person to person.
Learn more: A new remedy for celiac disease
The Latest on: Celiac disease
via Google News
The Latest on: Celiac disease
- Gluten-Free Pasta Market to rise due to increasing occurrence of celiac disease and gluten intoleranceon June 25, 2020 at 1:36 am
Over the past few years, there has been a significant rise in the number of the consumer having an intolerance to ...
- People’s Pharmacy: Older people can still get celiac diseaseon June 24, 2020 at 9:36 pm
When I heard a friend describe his symptoms of celiac disease, I could relate. My friend said that a simple blood test would reveal if I had celiac disease. So I asked my doctor for that and, bingo, ...
- deCODE Genetics: Loss of Function Variant in FLT3 Strongly Increases the Risk of Autoimmune Thyroid Disease and Other Autoimmune Diseaseson June 24, 2020 at 8:51 am
Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system, University of Iceland and the Karolinska Institute in Sweden, today publish a study ...
- The combination of genomics, transcriptomics and proteomics sheds light on autoimmune thyroid disease, other autoimmune diseases and AMLon June 24, 2020 at 8:40 am
Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system, University of Iceland and the Karolinska Institute ...
- Older people can still get celiac diseaseon June 21, 2020 at 6:00 am
Q: I am an 82-year-old healthy woman, active and self-sustaining. I was diagnosed with celiac disease eight years ago after two years of diarrhea that became unmanageable. When I heard a friend ...
- Celiac disease keeps me from the Eucharist. But communion is still possible.on June 17, 2020 at 12:41 pm
After three months of doctor visits, blood tests, an endoscopy and a colonoscopy, a gastroenterologist diagnosed me with celiac disease, an autoimmune disease that causes my immune system to attack my ...
- Celiac disease shares many genetic factors with T1Diabetes: TEDDY Reporton June 16, 2020 at 12:49 am
NIDDK study continues to look at possible factors that lead to the development of the diseases in childrenNew results and information surrounding potential 'triggers' of the autoimmune process ...
- Beyond Celiac Creates Summer Intern Council to Engage College Students in Mission for a Celiac Disease Cureon June 12, 2020 at 8:51 am
Beyond Celiac, an entrepreneurial nonprofit working as a catalyst to cure celiac disease and support the celiac disease community, is seeking a group of paid interns for the summer to assist with ...
- Chemical pollutant exposure linked to celiac disease in young peopleon June 11, 2020 at 9:07 am
Chemical pollutants — which are present in detergents, pesticides, and nonstick cookware — may contribute to the risk of developing celiac disease.
via Bing News